Amazon in talks with generic-drug makers

Press enter to search
Close search
Open Menu

Amazon in talks with generic-drug makers

By Gina Acosta - 12/01/2017

Amazon is holding meetings with makers of generic drugs about its potential entry into the pharmacy space.

According to CNBC, the conversations, including with generics giants Mylan and Sandoz, a unit of Novartis, have been high-level, and the nature of Amazon's plans isn't yet clear.

CNBC reported the conversations are about Amazon taking a role in drug purchasing, potentially disrupting a space now dominated by distributors McKesson, AmerisourceBergen and Cardinal Health. Generics manufacturers are eager to establish a relationship with Amazon as part of 2018 business plans.

Read more about Amazon's plans by clicking here.